Diagnosis

Sequential NIT Screening for MASH Reduces Biopsies and Costs

This study evaluated the diagnostic performance of non-invasive tests (NITs) like the FibroScan-AST (FAST) score, LSM-VCTE, FIB-4, and NFS for screening metabolic dysfunction-associated steatohepatitis (MASH) in clinical trials....

Jennifer Geremia,

MSPAS, PA-C
Physician Associate, Brigham and Women’s Hospital
and Teaching Hospital of Harvard Medical School

Study Develops Noninvasive MASH Dx Score

A study aimed to develop a noninvasive tool to diagnose high-risk metabolic dysfunction-associated steatohepatitis (MASH) using proteomics-derived serum markers and...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Advancements in MASLD Diagnosis: Non-Invasive Tools

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as NASH, is a growing health concern due to its association with...

CURATED BY:
Corrie Berk,
DNP, MBA, APRN

Detecting Significant Fibrosis in Hispanic Patients With MASLD

A recent study evaluated the performance of noninvasive tests (NITs) for detecting significant fibrosis in Hispanic patients with metabolic dysfunction–associated...

CURATED BY:
Corrie Berk,
DNP, MBA, APRN

Genetic Variants Tied to Cirrhosis Risk and Influence of Alcohol, Obesity

Recent research has identified 12 genetic variants, including 7 newly discovered ones, that are associated with an increased risk of...

CURATED BY:
Miu Lai (Milly) Ng,
FNP-BC, MPH (Harvard)

Alcohol’s Dual Impact: Balancing Risks and Benefits in Obesity and Heart Health

Recent research highlights the complex relationship between alcohol consumption, obesity, liver disease, and cardiovascular risk. Excessive alcohol intake is well-known...

CURATED BY:
Miu Lai (Milly) Ng,
FNP-BC, MPH (Harvard)

Global Survey of Stigma Among Physicians and Patients With NAFLD

A cross-sectional study was conducted to examine the stigma experienced by patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)...